Recent News
Friday, March 17, 2017

Position Available at Extera Partners

 »
Wednesday, December 21, 2016
Pfizer makes a $6 million equity investment in new shares in BioInvent
Lund, Sweden – 21 December 2016
 »
Tuesday, December 13, 2016
Acer Therapeutics obtains exclusive rights to NDA-enabling clinical data of the company’s lead product, VASEBRA™ (celiprolol), for the treatment of vascular Ehlers-Danlos Syndrome (vEDS)
 »
Thursday, October 20, 2016
Catalyst Biosciences Announces Agreement to Sell NNR Asset
 »
Thursday, October 20, 2016

Jacobs, Stratasys Partner to Advance Medical 3D Printing

 »
Thursday, October 20, 2016

Stratasys and Vital Images Partner on 3D Priting

 »
Tuesday, August 02, 2016

Catalyst Biosciences Announces Agreemen

 »
Monday, July 18, 2016
Censa Pharmaceuticals Inc. Secures Series A Financing Round Led by Arkin Bio-Ventures
 »
Monday, May 09, 2016
Acer Therapeutics Closes $8.15 Million Series B Financing
 »